» Articles » PMID: 17290054

Lung Cancer Incidence in Never Smokers

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2007 Feb 10
PMID 17290054
Citations 238
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Lung cancer is a leading cause of cancer death worldwide. Although smoking remains the predominant cause of lung cancer, lung cancer in never smokers is an increasingly prominent public health issue. However, data on this topic, particularly lung cancer incidence rates in never smokers, are limited.

Methods: We reviewed the existing literature on lung cancer incidence and mortality rates among never smokers and present new data regarding rates in never smokers from the following large, prospective cohorts: Nurses' Health Study; Health Professionals Follow-Up Study; California Teachers Study; Multiethnic Cohort Study; Swedish Lung Cancer Register in the Uppsala/Orebro region; and First National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study.

Results: Truncated age-adjusted incidence rates of lung cancer among never smokers age 40 to 79 years in these six cohorts ranged from 14.4 to 20.8 per 100,000 person-years in women and 4.8 to 13.7 per 100,000 person-years in men, supporting earlier observations that women are more likely than men to have non-smoking-associated lung cancer. The distinct biology of lung cancer in never smokers is apparent in differential responses to epidermal growth factor receptor inhibitors and an increased prevalence of adenocarcinoma histology in never smokers.

Conclusion: Lung cancer in never smokers is an important public health issue, and further exploration of its incidence patterns, etiology, and biology is needed.

Citing Articles

Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020s.

Mosleh B, Sarova P, Zehetmayer S, Oberndorfer F, Widder J, Prosch H Heliyon. 2025; 11(2):e42089.

PMID: 39925357 PMC: 11804590. DOI: 10.1016/j.heliyon.2025.e42089.


Particulate hexavalent chromium exposure induces DNA double-strand breaks and inhibits homologous recombination repair in rat and human lung tissues.

Lu H, Wise S, Toyoda J, Speer R, Croom-Perez T, Meaza I Chemosphere. 2024; 370():143982.

PMID: 39701314 PMC: 11750071. DOI: 10.1016/j.chemosphere.2024.143982.


Lymphatic vascular invasion: Diagnostic variability and overall survival impact on patients undergoing surgical resection.

Varlotto J, Voland R, Rassaei N, Zander D, DeCamp M, Khatri J JTCVS Open. 2024; 21:313-340.

PMID: 39534344 PMC: 11551250. DOI: 10.1016/j.xjon.2024.08.012.


56Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female Mice.

Finkelstein S, Patel R, Deland K, Mercer J, Starr B, Zhu D Radiat Res. 2024; 202(5):734-744.

PMID: 39307527 PMC: 11608577. DOI: 10.1667/RADE-24-00004.1.


Comparative study of lung cancer between smokers and nonsmokers: A real-world study based on the whole population from Tianjin City, China.

Zheng W, Jiang G, Wang C, Xun L, Shen C, Zhang S Tob Induc Dis. 2024; 22.

PMID: 39253306 PMC: 11382349. DOI: 10.18332/tid/192191.


References
1.
Jemal A, Ward E, Thun M . Contemporary lung cancer trends among U.S. women. Cancer Epidemiol Biomarkers Prev. 2005; 14(3):582-5. DOI: 10.1158/1055-9965.EPI-04-0554. View

2.
Alberg A, Brock M, Samet J . Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005; 23(14):3175-85. DOI: 10.1200/JCO.2005.10.462. View

3.
Le Calvez F, Mukeria A, Hunt J, Kelm O, Hung R, Taniere P . TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res. 2005; 65(12):5076-83. DOI: 10.1158/0008-5472.CAN-05-0551. View

4.
Shepherd F, Pereira J, Ciuleanu T, Tan E, Hirsh V, Thongprasert S . Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med. 2005; 353(2):123-32. DOI: 10.1056/NEJMoa050753. View

5.
Tsao M, Sakurada A, Cutz J, Zhu C, Kamel-Reid S, Squire J . Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med. 2005; 353(2):133-44. DOI: 10.1056/NEJMoa050736. View